[go: up one dir, main page]

TW339327B - Substituted benzoylguanidines, a process for their manufacture, their use as a medicament or diagnostic, as well as medicaments containing them - Google Patents

Substituted benzoylguanidines, a process for their manufacture, their use as a medicament or diagnostic, as well as medicaments containing them

Info

Publication number
TW339327B
TW339327B TW084112529A TW84112529A TW339327B TW 339327 B TW339327 B TW 339327B TW 084112529 A TW084112529 A TW 084112529A TW 84112529 A TW84112529 A TW 84112529A TW 339327 B TW339327 B TW 339327B
Authority
TW
Taiwan
Prior art keywords
medicament
diagnostic
manufacture
well
medicaments containing
Prior art date
Application number
TW084112529A
Other languages
Chinese (zh)
Inventor
Weichert Andreas
Lang Hans-Jochen
Schwark Jan-Robert
Albus Udo
Scholz Wolfgang
Brendel Joachim
Kleemann Heinz-Werner
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of TW339327B publication Critical patent/TW339327B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Benzoylguanidines or pharmaceutically acceptable salts as given in formula I (formula I) where R(1), R(4) and R(5) are hydrogen; R(2) halogen, alkyl of 1, 2, 3 or 4 carbon atoms or R(6)-C(OH)2-; R(3) is hydrogen or R(6)-C(OH)2-; and R(6) methyl trifluoride.
TW084112529A 1995-09-27 1995-11-24 Substituted benzoylguanidines, a process for their manufacture, their use as a medicament or diagnostic, as well as medicaments containing them TW339327B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95115240A EP0765867A1 (en) 1995-09-27 1995-09-27 Substituted benzoyl guanidines, process for their preparation, their use as antiarrhythmics or diagnostic agent as well as pharmaceuticals containing them

Publications (1)

Publication Number Publication Date
TW339327B true TW339327B (en) 1998-09-01

Family

ID=8219659

Family Applications (1)

Application Number Title Priority Date Filing Date
TW084112529A TW339327B (en) 1995-09-27 1995-11-24 Substituted benzoylguanidines, a process for their manufacture, their use as a medicament or diagnostic, as well as medicaments containing them

Country Status (20)

Country Link
US (1) US5747541A (en)
EP (1) EP0765867A1 (en)
JP (1) JPH09124584A (en)
KR (1) KR970015568A (en)
AR (1) AR004004A1 (en)
AU (1) AU6584696A (en)
BR (1) BR9603911A (en)
CA (1) CA2186580A1 (en)
CZ (1) CZ280896A3 (en)
HR (1) HRP960430A2 (en)
HU (1) HUP9602640A3 (en)
IL (1) IL119293A0 (en)
MX (1) MX9604338A (en)
NO (1) NO964053L (en)
NZ (1) NZ299445A (en)
PL (1) PL315050A1 (en)
SK (1) SK122596A3 (en)
TR (1) TR199600753A1 (en)
TW (1) TW339327B (en)
ZA (1) ZA968091B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19859727A1 (en) 1998-12-23 2000-06-29 Aventis Pharma Gmbh The use of inhibitors of the sodium-hydrogen exchanger for the manufacture of a medicament for the prevention of age-related organ dysfunctions, age-related illnesses for the prolongation of life
AU1898700A (en) * 1999-12-20 2001-07-03 Gho'st Holding B.V. Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and NA+/H+ exchange inhibitor
US6410563B1 (en) 1999-12-22 2002-06-25 Merck Frosst Canada & Co. Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
MY123585A (en) * 2000-03-23 2006-05-31 Merck Canada Inc Tri-aryl-substituted-ethane pde4 inhibitors.
US6639077B2 (en) 2000-03-23 2003-10-28 Merck Frosst Canada & Co. Tri-aryl-substituted-ethane PDE4 inhibitors
JP2003534328A (en) 2000-05-25 2003-11-18 メルク フロスト カナダ アンド カンパニー Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitors
US6740666B2 (en) 2000-12-20 2004-05-25 Merck & Co., Inc. Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
JP4460221B2 (en) 2001-05-24 2010-05-12 メルク フロスト カナダ リミテツド 1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitor
JO2311B1 (en) 2001-08-29 2005-09-12 ميرك فروست كندا ليمتد Alkyne-aryl phosphodiesterase-4 inhibitors
AU2003213783B2 (en) 2002-03-12 2007-01-25 Merck Sharp & Dohme Corp. Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
US7253218B2 (en) * 2004-03-01 2007-08-07 H.B. Fuller Company Sound damping compositions and methods for applying and baking same onto substrates
WO2007136636A1 (en) * 2006-05-17 2007-11-29 Childrens Hospital Los Angeles Research Institute Drug combinations to treat hyperproliferative disorders

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
DE3929582A1 (en) * 1989-09-06 1991-03-07 Hoechst Ag BENZOYLGUANIDINE, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICINE AND THE MEDICINE CONTAINING IT
CZ284456B6 (en) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Amino substituted benzylguanidines, process of their preparation and their use for preparing medicaments
DE59302959D1 (en) * 1992-02-15 1996-07-25 Hoechst Ag 3,5-Substituted benzoylguanidines, with antiarrhythmic effects and inhibitory effects on cell proliferation
EP0556673B1 (en) * 1992-02-15 1997-09-17 Hoechst Aktiengesellschaft Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as medicaments containing them
ATE147375T1 (en) * 1992-09-22 1997-01-15 Hoechst Ag BENZOYLGUANIDINES, METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE AS ANTIARRHYTHMICS
TW250479B (en) * 1992-12-15 1995-07-01 Hoechst Ag
TW250477B (en) * 1992-12-15 1995-07-01 Hoechst Ag
ATE151071T1 (en) * 1992-12-16 1997-04-15 Hoechst Ag 3,5-SUBSTITUTED AMINOBENZOYLGUANIDINES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICINE OR DIAGNOSTIC AND A MEDICINE CONTAINING THEM
EP0604852A1 (en) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 2,4-Substituted 5-(N-substituted-sulfamoyl) benzoylguanidines, as antiarrhythmic agents, inhibitors of the proliferation of cells and inhibitors of sodium-hydrogen exchange
ATE157351T1 (en) * 1993-02-20 1997-09-15 Hoechst Ag SUBSTITUTED BENZOYLGUANIDINES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICATION, AS INHIBITORS OF CELLULAR NA+/H+ EXCHANGE OR AS A DIAGNOSTIC, AND MEDICINE CONTAINING THEM
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4318658A1 (en) * 1993-06-04 1994-12-08 Hoechst Ag Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them
DE4318756A1 (en) * 1993-06-05 1994-12-08 Hoechst Ag Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them
US5372607A (en) * 1993-06-23 1994-12-13 Medtronic, Inc. Method and apparatus for monitoring pacemaker intervals
DE4325822A1 (en) * 1993-07-31 1995-02-02 Hoechst Ag Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them
DE4327176C1 (en) * 1993-08-13 1995-01-26 Metallgesellschaft Ag Tube furnace for the production of gas mixtures containing carbon monoxide
DE4344550A1 (en) * 1993-12-24 1995-06-29 Hoechst Ag Substituted 1-oxo-1,2-dihydro-isoquinolinoyl and 1,1-dioxo-2H-1,2-benzothiazinoylguanidines, processes for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them
TW415937B (en) * 1994-01-25 2000-12-21 Hoechst Ag Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE4402057A1 (en) * 1994-01-25 1995-08-03 Hoechst Ag Perfluoroalkyl-bearing phenyl-substituted alkylcarboxylic acid guanidines, processes for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them
DE4417004A1 (en) * 1994-05-13 1995-11-16 Hoechst Ag Perfluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
DE4421536A1 (en) * 1994-06-20 1995-12-21 Hoechst Ag Phenyl-substituted alkenylcarboxylic acid guanidines bearing perfluoroalkyl groups, processes for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them
DE4422685A1 (en) * 1994-06-29 1996-01-04 Hoechst Ag Ortho-amino-substituted benzoylguanidines, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them
DE4432106A1 (en) * 1994-09-09 1996-03-14 Hoechst Ag Heterocyclic N-oxide-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, medicament containing them and intermediates for their preparation
DE4432101A1 (en) * 1994-09-09 1996-03-14 Hoechst Ag Amino acid-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
DE4441880A1 (en) * 1994-11-24 1996-05-30 Hoechst Ag Substituted benzoylguanidines, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them
ES2139965T3 (en) * 1995-01-30 2000-02-16 Hoechst Ag BENZOILGUANIDINES SUBSTITUTED WITH GROUPS OF BASIC CHARACTER, PROCEDURE FOR THEIR PREPARATION, ITS USE AS A MEDICATION OR DIAGNOSTIC AGENT, AS WELL AS A MEDICINAL PRODUCT CONTAINING THEM.

Also Published As

Publication number Publication date
BR9603911A (en) 1998-06-09
PL315050A1 (en) 1997-04-01
US5747541A (en) 1998-05-05
ZA968091B (en) 1997-03-27
HU9602640D0 (en) 1996-11-28
CA2186580A1 (en) 1997-03-28
NO964053D0 (en) 1996-09-26
AR004004A1 (en) 1998-09-30
AU6584696A (en) 1997-04-10
NZ299445A (en) 1997-11-24
JPH09124584A (en) 1997-05-13
HRP960430A2 (en) 1998-02-28
HUP9602640A2 (en) 1997-05-28
MX9604338A (en) 1997-03-29
HUP9602640A3 (en) 1997-11-28
IL119293A0 (en) 1996-12-05
EP0765867A1 (en) 1997-04-02
CZ280896A3 (en) 1997-06-11
NO964053L (en) 1997-04-01
KR970015568A (en) 1997-04-28
SK122596A3 (en) 1997-05-07
TR199600753A1 (en) 1997-04-22

Similar Documents

Publication Publication Date Title
TW336939B (en) Lipopeptide derivatives, a process for their preparation and their use
TW349946B (en) Novel naphthyl compounds and their process for preparation and pharmaceutical compositions containing same
AU3559193A (en) New 3',5'-di-tert-butyl-4'-hydroxy flavones, process for the preparation thereof and pharmaceutical compositions containing them
TW339327B (en) Substituted benzoylguanidines, a process for their manufacture, their use as a medicament or diagnostic, as well as medicaments containing them
EP0163599A3 (en) Pyrimidopyrimidine derivatives, processes for producing them, pharmaceutical compositions containing them and their use as anti-allergic agents
MY100095A (en) 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
ES8406992A1 (en) Beta, gamma-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound
ES8404360A1 (en) 7-Acylamino-3-cephem-4-carboxylic acid derivatives, processes for the preparation of the same and pharmaceutical composition comprising the same.
HUT54362A (en) Process for producing cumarin derivatives and pharmaceutical compositions containing them
MY137475A (en) Chemical compounds.
HUT50845A (en) Process for producing 14,17beta-ethano-14beta-estratrienes and pharmaceutical compositions comprising same
JPS57185282A (en) Benzopyrane ether, manufacture and anti-allergic medicine containing same
ES474367A1 (en) New benzo [d] thiazole derivatives, process for their preparation and their therapeutic applications
GB2232890B (en) Use of steroidal compounds as anti-fungal agents
IE780926L (en) Chromene derivatives
SE8603589D0 (en) METHYLENDIOXIFENANTRAN AND STYLBAN DERIVATIVES
AU2994589A (en) Novel basic-substituted 5-halo-thienoisothiazol-3-(2h)-one-1,1-dioxides, process for the preparation thereof, and pharmaceutical preparations containing these compounds
GR3003769T3 (en)
ES2009553A6 (en) 2,3-Dihydro-2-oxo-3-benzofuranyl acetic-acid derivatives and pharmaceutical compositions containing them.
DE3166665D1 (en) Dibenzocycloheptenylidenes and their use in pharmaceutical compositions
EP0204172A3 (en) Phenylpyrazine derivatives, processes for preparing them, pharmaceutical composition and use
TW355184B (en) Substituted thiophenylsulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
AU1675692A (en) Medicaments containing azacyclodiphosphonic acid derivatives, novel azacyclodiphosphonic acid derivatives and process for producing them
HUT59595A (en) Process for producing antidepressant and antistress pharmaceutical compositons containing phenyl-ethanol-amino-tetralines
EP0382854A4 (en) Indoleacetic acid derivatives, process for their preparation, and medicines containing same as active ingredients